chemoproteomics – Talk Bio

Belharra Biotech Cuts 21 Jobs Amid Industry-Wide Restructuring

5 months ago talkbio0Tagged Belharra, biotech, chemoproteomics, Industry, restructuring

Belharra Biotech, layoffs, chemoproteomics, biotech industry, restructuring

Otsuka Pharmaceutical Acquires Jnana Therapeutics for $800M to Develop PKU Treatment

9 months ago talkbio0Tagged Acquisition (action), chemoproteomics, Dosage Forms, Jnana, JNT-517, Metabolic Diseases, Otsuka, Phenylketonurias, PKU, Rapid

Otsuka Pharmaceutical, Jnana Therapeutics, PKU, phenylketonuria, JNT-517, RAPID chemoproteomics platform, rare metabolic disorder, biotech acquisition

Sanofi Partners with Belharra to Tackle ‘Undruggable’ Immunology Targets in $700M Deal

10 months ago talkbio0Tagged Belharra, chemoproteomics, Immunology, sanofi, small molecule therapies, targets

Sanofi, Belharra Therapeutics, Immunology, Small Molecule Therapies, Chemoproteomics, Undruggable Targets